Found 77 matching trials
Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer PHASE1 This is a randomized, open, comparative, multi-centre study which will recr...
Show More Location
Institut Ste Catherine
Learn More & Join Trial
Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC PHASE1 This is an open-label, multicenter, 2-arm study to evaluate the safety and ...
Show More Location
Research Facility
Learn More & Join Trial
Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach PHASE2 Combined-modality treatment of localized muscle invasive bladder cancer inc...
Show More Location
Instituto Catalán de Oncología Badalona
Learn More & Join Trial
......SMARTEST Trial...... PHASE2 The SMARTEST trial is a phase II non-blinded randomized trial designed to e...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma PHASE2 Neoadjuvant chemo- and immunotherapy ameliorate the recurrence rate of chol...
Show More Location
Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale
Learn More & Join Trial
HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC PHASE2 The treatment options for unresectable HCC have rapidly developed, and immu...
Show More Location
Hunan Provincial People's Hospital(The First Affiliated Hospital of Hunan Normal University)
Learn More & Join Trial
TheraSphere With Durvalumab and Tremelimumab for HCC PHASE2 The objective of the ROWAN clinical study is to assess the efficacy of loca...
Show More Status
Active Not Recruiting
Location
University of California San Diego
Learn More & Join Trial
Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab NA Several cancer immunotherapies that target the PD-L1/PD-1 pathway (i.e., ch...
Show More Learn More & Join Trial
Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract PHASE2 This study is being done test to test the safety and effectiveness of durva...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial
Trial in Patients With Relapsed Ovarian Cancer PHASE2 The overall objectiv is to obtain preliminary evidence of efficacy of novel...
Show More Learn More & Join Trial